Genetic variation in apolipoprotein H (β2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus
- 1 November 1999
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 8 (9) , 742-750
- https://doi.org/10.1191/096120399678840909
Abstract
Apolipoprotein H (apoH, protein; APOH, gene) is a required cofactor for the production of antiphospholipid antibodies (APA). In this study we have examined whether genetic variation in the APOH gene affects variation in risk for systemic lupus erythematosus (SLE), occurrence of antiphospholipid antibodies (APA), anti-apoH, and plasma apoH concentrations. A total of 222 white SLE women were screened for four APOHpolymorphisms (codons 88, 247, 306, and 316) by polymerase chain reaction, and for plasma apoH concentrations by ELISA. Of these, 29.3% were positive for APA (APA-positive group) and 31.1% for anti-apoH. None of the four APOH polymorphisms were significantly associated with variation in risk for SLE. The codons 306 and 316 polymorphisms showed significant, gene-dosage effects on plasma apoH concentrations (P<0.0001) and explained 30% and 13%, respectively, of the residual variation in apoH concentrations. No significant association was observed between anti-apoH status and APOH polymorphisms or plasma apoH levels. However, plasma apoH concentrations were significantly higher in patients positive for APA than in patients negative for APA (18.5±4.0 mg/dl vs 17.1+3.8 mg/dl; P=0.02). The distribution of the Trp3l6Ser polymorphism was significantly different between the APA-positive and APA-negative groups. The frequency of the mutant allele (Ser316) was significantly lower in the APA-positive group than the APA-negative group (3.1% vs 12.1% P < 0.04), indicating that the Ser316 mutation is protective against the production of phospholipid-apoH dependent APA. Our data indicate that common genetic variation in the APOH gene is a significant determinant of plasma apoH variation in SLE patients, and the Trp3l6Ser polymorphism appears to provide protection against the production of APA in SLE patients.Keywords
This publication has 26 references indexed in Scilit:
- Genetic basis of systemic lupus erythematosusCurrent Opinion in Immunology, 1996
- Systemic Lupus ErythematosusCell, 1996
- IgG2 subclass restriction of anti-β2 glycoprotein 1 antibodies in autoimmune patientsClinical and Experimental Immunology, 1994
- Nucleotide sequence and expression of the human gene encoding apolipoprotein H (β2-glycoprotein I)Gene, 1991
- Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein IBiochemical Journal, 1991
- Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).Proceedings of the National Academy of Sciences, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- Complete amino acid sequence of human plasma beta 2-glycoprotein I.Proceedings of the National Academy of Sciences, 1984
- Investigations on the genetics and population genetics of the ?2 polymorphismHuman Genetics, 1970
- Genetic studies on the deficiency of ß2-glycoprotein I of human serumHuman Genetics, 1968